Prostate cancer is the second most common form of cancer in United States, and second leading cause of death from cancer after lung cancer. Traditional screening and diagnosis involves routine PSA (Prostate Specific Antigen) testing and highly invasive transrectal ultrasound-guided prostate biopsy post high PSA. The current protocol leaves a lot to be desired as the specificity and sensitivity of PSA and ultrasound-guided biopsies have been shown to be fairly low. MRI has been shown to be highly specific and sensitive to detect clinically significant cancers. However, MRI is considered a high-end imaging modality that is very costly, especially in the United States. The talk will focus on comparing the healthcare costs between using MRI for screening, diagnosis and targeted treatment of prostate cancer compared to current standard-of-care.

Event Information

Event Topic:
Cost-Effectiveness of MRI for Prostate Cancer Disease Management: a Health Economics Approach

Event Description:

Date/Time:
Date(s) - 10/16/18
8:30 am - 10:00 am

Event Location:
Other: NOVA - 505 West Olive Ave, Sunnyvale- Suite 799

Speaker Information

Event Speaker:
Dinesh Kumar

Event Speaker Title:
Chief Operating Officer

Event Speaker Company:
Promaxo

Event Speaker Bio:

Dinesh currently works as Chief Operations Officer at Promaxo. He is a seasoned medical devices executive who has brought several medical devices to market that redefined standard-of-care. He has overseen development and launch of products in cardiovascular, urology and vascular diagnostics and treatment domains. Dinesh also mentors and advises medical device startups. He completed his PhD in electrical and computer engineering from University of Iowa, and MBA from University of California, Berkeley.

Event Details

Cost:
$0

Add To Calendar